AlphAIalphai — Financial news for AI agents
Zacks CommentaryOCT 303 min read$HR

Healthcare Realty Trust (HR) Tops Q3 FFO and Revenue Estimates

Healthcare Realty Trust (HR) delivered FFO and revenue surprises of +2.50% and +0.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Original reporting
Zacks Commentary · Zacks Equity Research
Published Oct 30, 2025, 10:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Oct 31, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Healthcare Realty Trust (HR) Tops Q3 FFO and Revenue Estimates — source image
Source · www.zacks.com
Decision brief

The 30-second read

$HRBullishMed
01

Why it matters

Earnings beat suggests improved investor confidence, potentially leading to stock price appreciation.

02

Market read

The earnings report is relevant for investors in healthcare REITs and real estate sectors, with immediate impact on HR stock.

03

What to watch

Broader economic conditions and interest rate trends could offset positive earnings impact.

Timing: Immediate to short-term trading window, given earnings report date.

Background

Healthcare Realty Trust reported Q3 earnings surpassing estimates, signaling operational strength.

Company-level read

Ticker impact

$HRBullishHigh confidence
Context

Primary focus of the news, relevant for trading decisions.

Expected impact

Moderate upward movement in HR stock price over the short term.

Evidence & confidence

Earnings beats often lead to short-term price increases; the positive surprise supports bullish sentiment.

Market effects

Sector

Positive sentiment for healthcare REITs, potential sector-wide uplift.

Regional

Limited regional impact, primarily affecting US healthcare real estate sector.

Global

Low, as the news pertains to a US-based REIT and does not influence global markets significantly.

Counterpoint

What could challenge this read

Earnings beats may already be priced in; potential for a short-term correction due to profit-taking.

Key entities

  • Company
    Healthcare Realty Trust

    A real estate investment trust focusing on healthcare properties.

  • Source
    Zacks Equity Research

    Financial research and analysis provider.

Read at source← All news

Related articles

AUG 8
$HRMedAI 8/10

Healthcare Realty Trust (HR) Q2 2026 Earnings Call Transcript

Healthcare Realty Trust (HR) reported Q2 2026 normalized FFO of $0.41/share and same-store cash NOI growth of 5.1% y/y. It raised normalized FFO guidance to $1.62 to $1.66/share and same-store cash NOI growth guidance to 4.3% to 5.0%. GAAP net loss was $0.13/share after $42.7m impairments. HR also discussed $200m JV acquisitions, $83m asset dispositions, and $75m Q2 repurchases.

fool.com6 min
JUL 31
$HRMed

Healthcare Realty Trust: Q2 Earnings Snapshot

Healthcare Realty Trust (HR) reported Q2 funds from operations of $143.7 million, or 41 cents per share, beating a Zacks-surveyed analyst average of 40 cents. The company posted a Q2 loss of $43.5 million, or 13 cents per share, and revenue of $281.8 million. Full-year FFO guidance is $1.62 to $1.66 per share.

local3news.com2 min
JUL 30
$HRHigh

Healthcare Realty Trust Inc (HR): Results of Operations and Financial Condition

Healthcare Realty Trust Inc (HR) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release HEALTHCARE REALTY REPORTS SECOND QUARTER 2026 RESULTS AND FURTHER INCREASES FULL YEAR 2026 GUIDANCE NASHVILLE, Tennessee, July 30, 2026. Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2026. I n addition, t

SEC EDGAR 8-K6 min
AUG 28
$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

yahoo.com3 min
AUG 28
$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi

wisbusiness.com3 min